Here’s a rapid-fire update on all 33 stocks in our portfolio, including those Cramer would buy on dips
Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting.
Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting.
A new study has found that the overwhelming majority of protein foods such as meat and fish are contaminated with microplastics. The comprehensive study, conducted by researchers at the nonprofit Ocean Conservancy, found that approximately 88% of protein samples tested contained microplastic particles. “Highly processed products contained the most microplastics per gram,” the study said…
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Monday said its Covid vaccine sales plunged by about two-thirds in 2023 to $6.7 billion, as fewer people rolled up their sleeves for an updated version of the jab. The revenue from the shots met Moderna’s forecast for the year, even as sales plummeted from the…
This isn’t the first time Jackman has reminded people to wear their sunscreen in an Instagram post. In 2013, Jackman revealed he had basal cell carcinoma on his nose, adding, “Get yourself checked. And USE sunscreen!!!” Similarly, Khloé Kardashian recently had two biopsies after noticing a small bump on her cheek that wouldn’t go away,…
Experts, including psychologists who specialize in body image, agree — making comments on someone’s appearance can be harmful, even if you think you have good intentions. Since you may not know what someone is going through, making comments about a person’s body, whether it’s the size, shape, or just about anything else, is not only…
We cover sleep a lot. We’ve done thorough research to clue readers in on the best sheets to buy, including top-selling bamboo options and those suitable for hot sleepers. And, thanks to our anonymous shopping data, we’ve noticed that there are a few sets in particular that readers can’t seem to get enough of. Investing in a…
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%. The deal will help expand Bristol Myers’ drug pipeline after…